Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
| Conditions: | Small Cell Carcinoma|Mesothelioma|Non-Small-Cell Lung Carcinoma |
| Start Date: | May 1, 2002 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00037817 |
| Study Type: | Interventional |
| Intervention: | Drug: Decitabine|Drug: Depsipeptide |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 34 |
| Funded By: | NIH |
| First Received: | May 21, 2002 |
| End Date: | November 1, 2009 |
| Last Updated: | October 7, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
